Monday, 14 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14389
Articles
Company
Deals
Huadong Medicine and Shian Biotech Advance siRNA Obesity Therapy to Preclinical Stage
February 10, 2026
Company
Deals
Bao Pharma Partners with Shanghai RAAS to Develop Subcutaneous Blood Products Using Hyaluronidase Technology
February 10, 2026
Company
Drug
Delonix Bioworks’ DX-104 Becomes First China-Approved Engineered OMV Vaccine, Targets $1.3 Billion MenB Market
February 9, 2026
Company
Medical Device
Peijia Medical Files CE Mark for GeminiOne TEER System in European Mitral Regurgitation Market
February 9, 2026
Company
Novartis Breaks Ground on $23 Billion US Biomedical Research Center in San Diego
February 9, 2026
Company
Drug
Sino Biopharm Completes Phase III Enrollment for LM-302 ADC in Gastric Cancer
February 9, 2026
Company
Drug
Gilead’s Kite Pharma Secures FDA Label Expansion for Yescarta in Primary CNS Lymphoma
February 9, 2026
Company
Medical Device
Jenscare Scientific’s LuX-Valve Plus Wins FDA Nod for US Pivotal Trial in Tricuspid Regurgitation
February 9, 2026
Company
Drug
Hengrui Pharma’s HRS-4642 Wins Breakthrough Therapy Designation for KRAS G12D Pancreatic Cancer
February 9, 2026
Company
Drug
Pfizer’s Hympavzi Wins FDA Priority Review for Pediatric Hemophilia Expansion
February 9, 2026
Company
Drug
Zhongsheng Pharma Reports Positive Phase III Data for Onradivir Pediatric and Adolescent Influenza Trials
February 9, 2026
Company
Drug
InnoCare Pharma’s ICP-538 Becomes First VAV1 Molecular Glue Degrader to Enter China Clinical Trials
February 9, 2026
1
2
…
163
164
165
166
167
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?